EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study

Maja Thaarup, Sara Jacobsen, Peter Brønnum Nielsen, Chalotte Winther Nicolajsen, Nikolaj Eldrup, Christian Nikolaj Petersen, Christian-Alexander Behrendt, Marie Dahl, Anette Arbjerg Højen, Mette Søgaard

European Journal of Vascular and Endovascular Surgery · 2024

DOI: 10.1016/j.ejvs.2024.02.002 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2024. Verfasst von Maja Thaarup und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Peripheral Arterial Disease, Aspirin, Clopidogrel. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karen Elise Jensen Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Adherence to antiplatelet therapy is recommended but unexplored in patients with symptomatic lower extremity peripheral arterial disease (PAD). Therefore, this study aimed to determine adherence and persistence to antiplatelet therapy in patients with PAD, defined as intermittent claudication and chronic limb threatening ischaemia. DESIGN: Population based nationwide cohort study. METHODS: This study included all Danish citizens aged ≥ 40 years with a first inpatient or outpatient diagnosis of symptomatic PAD between 2010 - 2017, and who had at least one prescription claim for aspirin and/or clopidogrel within 90 days after diagnosis. Adherence was determined by the proportion of days covered (PDC) during the first year after diagnosis. Persistence was defined as no treatment gap ≥ 30 days between prescription renewals over three year follow up. RESULTS: A total of 39 687 patients were eligible for inclusion, of whom 23 279 (58.7%) claimed a prescription for aspirin and/or clopidogrel within 90 days of diagnosis. Among these, 12 898 (55.4%) were prevalent users, while the remainder comprised new users who initiated the therapy after the index PAD diagnosis. The mean PDC was 74.5% (SD 35.0%) for prevalent users and 60.5% (SD 30.5%) for new users. Adherence increased with age and number of concomitant drugs. The overall one year cumulative incidence treatment discontinuation was 13.0% (95% CI 12.5 - 13.4%) overall, 17.2% (CI 16.6 - 17.9%) for prevalent users, and 7.9% (CI 7.4 - 8.4%) for new users. At three year follow up, the cumulative incidence of discontinuation was 31.5% (CI 30.9 - 32.2%) overall, 44.6% (CI 43.7 - 45.4%) for prevalent users, and 14.6% (CI 13.9 - 15.3) for new users. CONCLUSION: Less than 60% of patients with newly diagnosed symptomatic PAD claimed a prescription for antiplatelet therapy within 90 days of diagnosis, and both adherence and persistence were moderate during the first year after diagnosis. These findings underscore the importance of efforts to improve the initiation and continuation of antiplatelet therapy in patients with PAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsPeripheral Arterial DiseaseAspirinClopidogrelLower ExtremityDrug MonitoringHumansMaleFemaleDenmarkAgedMiddle AgedAged, 80 and overTime FactorsIntermittent ClaudicationAdultIschemiaTreatment Outcome

Stichwörter der Autor:innen

AdherenceAntiplatelet therapyPeripheral artery diseasePersistenceSecondary prevention

Substanzen

Platelet Aggregation InhibitorsAspirinClopidogrel

Autor:innen und Institutionen

  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg University Hospital, Denmark.
  • Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark; Danish Centre for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg University Hospital, Denmark.
  • Department of Vascular Surgery, Viborg Regional Hospital, Viborg, Denmark.
  • Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Department of Vascular Surgery, Aalborg University Hospital, Aalborg, Denmark.

Förderung

  • Karen Elise Jensen Foundation

Zitieren

APA

Thaarup, M., Jacobsen, S., Nielsen, P. B., Nicolajsen, C. W., Eldrup, N., Petersen, C. N., Behrendt, C. A., Dahl, M., Højen, A. A., & Søgaard, M. (2024). Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2024.02.002

Vancouver

Thaarup M, Jacobsen S, Nielsen PB, Nicolajsen CW, Eldrup N, Petersen CN, et al. Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study. European Journal of Vascular and Endovascular Surgery. 2024. doi:10.1016/j.ejvs.2024.02.002

BibTeX
@article{Thaarup2024,
  author = {Thaarup, Maja and Jacobsen, Sara and Nielsen, Peter Brønnum and Nicolajsen, Chalotte Winther and Eldrup, Nikolaj and Petersen, Christian Nikolaj and Behrendt, Christian-Alexander and Dahl, Marie and Højen, Anette Arbjerg and Søgaard, Mette},
  title = {Adherence and Persistence to Antiplatelet Therapy in Lower Extremity Peripheral Arterial Disease: A Danish Population Based Cohort Study},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2024},
  doi = {10.1016/j.ejvs.2024.02.002}
}
Kostenlos starten →